Financial Comparison: Cronos Group vs. Lyra Therapeutics
1 report, 1 independent
Updated Sep 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A comparison of Cronos Group and Lyra Therapeutics found that Cronos Group has higher revenue and earnings than Lyra Therapeutics. Cronos Group's stock price is 6% less volatile than the S&P 500, while Lyra Therapeutics' is 42% less volatile. Lyra Therapeutics is currently trading at a lower price-to-earnings ratio than Cronos Group.
From dailypolitical.com
Why it matters
Equities research analysts believe Cronos Group is more favorable than Lyra Therapeutics due to its stronger consensus rating and higher possible upside. Cronos Group has 8.7% institutional ownership, compared to 95% for Lyra Therapeutics.
From dailypolitical.com